Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
Work
Year: 2009
Type: article
Source: Blood
Institutions Innate Pharma (France), Novo Nordisk (Denmark), University of Perugia, The Ohio State University, University of Genoa +3 more
Cites: 45
Cited by: 377
Related to: 10
FWCI: 8.122
Citation percentile (by year/subfield): 99.99
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green